Literature DB >> 24139086

Determining minimally important change thresholds for the Seizure Severity Questionnaire (SSQ).

Joyce A Cramer1, Christine de la Loge2, Yves Brabant3, Simon Borghs4.   

Abstract

The Seizure Severity Questionnaire (SSQ) was developed to evaluate changes in seizure severity and bothersomeness. Determination of a threshold value reflecting meaningful patient benefit on the SSQ would improve clinical interpretation of scale results. The objective of this analysis was to define a minimally important change (MIC) threshold for the SSQ, using data from patients with treatment-resistant partial-onset seizures from two clinical trials (N=776). Minimally important change thresholds were calculated using standard anchor-based methods, with the Patient Global Impression of Change (PGIC) score as the anchor with the categories of 'much improved,' 'minimally improved,' 'much worsened,' and 'minimally worsened' combined. The calculated MIC thresholds (range: 0.34 to 0.50) suggest that a 0.48-point change in the SSQ total score reflects a clinically meaningful change in seizure severity from the patients' perspective.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Minimally important change; Patient Global Impression of Change (PGIC); Patient-reported outcome; Seizure Severity Questionnaire (SSQ); Seizure severity; Severity

Mesh:

Year:  2013        PMID: 24139086     DOI: 10.1016/j.yebeh.2013.09.006

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  3 in total

1.  How bad are your seizures and did the treatment help?

Authors:  Robin Grant
Journal:  Neuro Oncol       Date:  2016-11-16       Impact factor: 12.300

2.  Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.

Authors:  Elizabeth Thiele; Eric Marsh; Maria Mazurkiewicz-Beldzinska; Jonathan J Halford; Boudewijn Gunning; Orrin Devinsky; Daniel Checketts; Claire Roberts
Journal:  Epilepsia       Date:  2019-02-11       Impact factor: 5.864

3.  Developing a Conceptual Disease Model of Patient Experiences and Identifying Patient-Reported Clinical Outcome Assessments for Use in Trials of Treatments for Focal Onset Seizures.

Authors:  Dorothee Oberdhan; Elizabeth Bacci; Jennifer N Hill; Andrew Palsgrove; Asha Hareendran
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-22       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.